semaglutide plus methylcobalamin + Compounded Semaglutide+B12 - Team Wellcore

Disclaimer These therapies are not approved by the FDA to diagnose, treat, cure, or prevent any disease

Antacids: Antacids work by neutralizing excess stomach acid which can sometimes cause nausea

Semaglutide, a GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, does not have an established lethal dose in humans

However, significant weight loss may lead to diabetes remission in some patients, requiring ongoing monitoring but potentially less medication

Beyond convenient home delivery, NovoCare also supports patients with benefit verification, refill reminders, and access to live support from a NovoCare case manager

Don't allow initial GI side effects to derail potentially transformative treatment